Clinical Trial Update: Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma

View source ↗

Summary

This clinical trial update reports on using serial ctDNA and molecular residual disease monitoring to assess disease burden in neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Neuroblastoma | Status: RECRUITING